🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Differentiated Thyroid Cancer (DTC)

Adjuvant Radiotherapy in High Risk Locally Advanced DTC NCT06558981Phase 31 site📍 Shanghai Fudan University · Tests: Radiotherapy, radioiodine treatment Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer NCT06898437EARLY Phase 11 site📍 Beijing Peking Union Medical College Hospital · Tests: 177Lu-LNC1004 Injection Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC) NCT07092514Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Lenvatinib Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer NCT06359847Phase 21 site📍 Beijing Beijing Scitech-Mq Pharmaceuticals Limited · Tests: ST-1898 tablets Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment NCT06405217NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Recombinant Human Thyroid Stimulating Hormone A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer NCT07287748Phase 11 site📍 Kashiwa Alpha Fusion Inc. · Tests: [211At]NaAt The EMIRATES Study NCT06855680n/a1 site📍 Wigan Royal Marsden NHS Foundation Trust Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer NCT06980103NA3 sites📍 Washington D.C.📍 Washington D.C.📍 Falls Church Georgetown University · Tests: Decision Aid, Usual Care Targeted Therapy to Increase RAI Uptake in Metastatic DTC NCT05024929n/a9 sites📍 San Francisco📍 Atlanta📍 Boston Children's Hospital of Philadelphia · Tests: Whole body scan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy